 | • レポートコード：QYR9N7960 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、むずむず足症候群のグローバル市場について調査・分析したレポートで、種類別（薬理学療法、非薬理学療法）、用途別（<35歳、35〜50歳、> 50歳）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・むずむず足症候群の世界市場規模 ・主要企業別市場シェア ・むずむず足症候群の世界市場規模：種類別（薬理学療法、非薬理学療法） ・むずむず足症候群の世界市場規模：用途別（<35歳、35〜50歳、> 50歳） ・むずむず足症候群のアメリカ市場規模（種類別、用途別） ・むずむず足症候群のヨーロッパ市場規模（種類別、用途別） ・むずむず足症候群の中国市場規模（種類別、用途別） ・むずむず足症候群の日本市場規模（種類別、用途別） ・むずむず足症候群の東南アジア市場規模（種類別、用途別） ・むずむず足症候群のインド市場規模（種類別、用途別） ・むずむず足症候群の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・むずむず足症候群の世界市場予測（2019年-2025年） ・むずむず足症候群の地域別市場予測（2019年-2025年） ... |
Restless legs syndrome (RLS) is a neurological disease. RLS is also called as Willis-Ekbom disease. Patients suffering from RLS disease have an irresistible desire to move their feet. The continual movement of the legs leads to pain in the limbs, which leads to the unusual sleep pattern of patients.In 2018, the global Restless Legs Syndrome market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Restless Legs Syndrome status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Restless Legs Syndrome development in United States, Europe and China.
The key players covered in this study
GlaxoSmithKline plc.
Ligand Pharmaceuticals Incorporated
axxonis Pharma AG
Kyowa Hakko Kirin
Jazz Pharmaceuticals
Omeros Corporation
Manhattan Pharmaceuticals
Boehringer Ingelheim GmbH
UCB SA
Market segment by Type, the product can be split into
Pharmacological Therapy
Non-Pharmacological Therapy
Market segment by Application, split into
< 35 Years Old
35-50 Years Old
> 50 Years Old
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Restless Legs Syndrome status, future forecast, growth opportunity, key market and key players.
To present the Restless Legs Syndrome development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Restless Legs Syndrome are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Restless Legs Syndrome Market Size Growth Rate by Type (2014-2025)
1.4.2 Pharmacological Therapy
1.4.3 Non-Pharmacological Therapy
1.5 Market by Application
1.5.1 Global Restless Legs Syndrome Market Share by Application (2014-2025)
1.5.2 < 35 Years Old
1.5.3 35-50 Years Old
1.5.4 > 50 Years Old
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Restless Legs Syndrome Market Size
2.2 Restless Legs Syndrome Growth Trends by Regions
2.2.1 Restless Legs Syndrome Market Size by Regions (2014-2025)
2.2.2 Restless Legs Syndrome Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Restless Legs Syndrome Market Size by Manufacturers
3.1.1 Global Restless Legs Syndrome Revenue by Manufacturers (2014-2019)
3.1.2 Global Restless Legs Syndrome Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Restless Legs Syndrome Market Concentration Ratio (CR5 and HHI)
3.2 Restless Legs Syndrome Key Players Head office and Area Served
3.3 Key Players Restless Legs Syndrome Product/Solution/Service
3.4 Date of Enter into Restless Legs Syndrome Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Restless Legs Syndrome Market Size by Type (2014-2019)
4.2 Global Restless Legs Syndrome Market Size by Application (2014-2019)
5 United States
5.1 United States Restless Legs Syndrome Market Size (2014-2019)
5.2 Restless Legs Syndrome Key Players in United States
5.3 United States Restless Legs Syndrome Market Size by Type
5.4 United States Restless Legs Syndrome Market Size by Application
6 Europe
6.1 Europe Restless Legs Syndrome Market Size (2014-2019)
6.2 Restless Legs Syndrome Key Players in Europe
6.3 Europe Restless Legs Syndrome Market Size by Type
6.4 Europe Restless Legs Syndrome Market Size by Application
7 China
7.1 China Restless Legs Syndrome Market Size (2014-2019)
7.2 Restless Legs Syndrome Key Players in China
7.3 China Restless Legs Syndrome Market Size by Type
7.4 China Restless Legs Syndrome Market Size by Application
8 Japan
8.1 Japan Restless Legs Syndrome Market Size (2014-2019)
8.2 Restless Legs Syndrome Key Players in Japan
8.3 Japan Restless Legs Syndrome Market Size by Type
8.4 Japan Restless Legs Syndrome Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Restless Legs Syndrome Market Size (2014-2019)
9.2 Restless Legs Syndrome Key Players in Southeast Asia
9.3 Southeast Asia Restless Legs Syndrome Market Size by Type
9.4 Southeast Asia Restless Legs Syndrome Market Size by Application
10 India
10.1 India Restless Legs Syndrome Market Size (2014-2019)
10.2 Restless Legs Syndrome Key Players in India
10.3 India Restless Legs Syndrome Market Size by Type
10.4 India Restless Legs Syndrome Market Size by Application
11 Central & South America
11.1 Central & South America Restless Legs Syndrome Market Size (2014-2019)
11.2 Restless Legs Syndrome Key Players in Central & South America
11.3 Central & South America Restless Legs Syndrome Market Size by Type
11.4 Central & South America Restless Legs Syndrome Market Size by Application
12 International Players Profiles
12.1 GlaxoSmithKline plc.
12.1.1 GlaxoSmithKline plc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Restless Legs Syndrome Introduction
12.1.4 GlaxoSmithKline plc. Revenue in Restless Legs Syndrome Business (2014-2019)
12.1.5 GlaxoSmithKline plc. Recent Development
12.2 Ligand Pharmaceuticals Incorporated
12.2.1 Ligand Pharmaceuticals Incorporated Company Details
12.2.2 Company Description and Business Overview
12.2.3 Restless Legs Syndrome Introduction
12.2.4 Ligand Pharmaceuticals Incorporated Revenue in Restless Legs Syndrome Business (2014-2019)
12.2.5 Ligand Pharmaceuticals Incorporated Recent Development
12.3 axxonis Pharma AG
12.3.1 axxonis Pharma AG Company Details
12.3.2 Company Description and Business Overview
12.3.3 Restless Legs Syndrome Introduction
12.3.4 axxonis Pharma AG Revenue in Restless Legs Syndrome Business (2014-2019)
12.3.5 axxonis Pharma AG Recent Development
12.4 Kyowa Hakko Kirin
12.4.1 Kyowa Hakko Kirin Company Details
12.4.2 Company Description and Business Overview
12.4.3 Restless Legs Syndrome Introduction
12.4.4 Kyowa Hakko Kirin Revenue in Restless Legs Syndrome Business (2014-2019)
12.4.5 Kyowa Hakko Kirin Recent Development
12.5 Jazz Pharmaceuticals
12.5.1 Jazz Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Restless Legs Syndrome Introduction
12.5.4 Jazz Pharmaceuticals Revenue in Restless Legs Syndrome Business (2014-2019)
12.5.5 Jazz Pharmaceuticals Recent Development
12.6 Omeros Corporation
12.6.1 Omeros Corporation Company Details
12.6.2 Company Description and Business Overview
12.6.3 Restless Legs Syndrome Introduction
12.6.4 Omeros Corporation Revenue in Restless Legs Syndrome Business (2014-2019)
12.6.5 Omeros Corporation Recent Development
12.7 Manhattan Pharmaceuticals
12.7.1 Manhattan Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Restless Legs Syndrome Introduction
12.7.4 Manhattan Pharmaceuticals Revenue in Restless Legs Syndrome Business (2014-2019)
12.7.5 Manhattan Pharmaceuticals Recent Development
12.8 Boehringer Ingelheim GmbH
12.8.1 Boehringer Ingelheim GmbH Company Details
12.8.2 Company Description and Business Overview
12.8.3 Restless Legs Syndrome Introduction
12.8.4 Boehringer Ingelheim GmbH Revenue in Restless Legs Syndrome Business (2014-2019)
12.8.5 Boehringer Ingelheim GmbH Recent Development
12.9 UCB SA
12.9.1 UCB SA Company Details
12.9.2 Company Description and Business Overview
12.9.3 Restless Legs Syndrome Introduction
12.9.4 UCB SA Revenue in Restless Legs Syndrome Business (2014-2019)
12.9.5 UCB SA Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Restless Legs Syndrome Key Market Segments
Table Key Players Restless Legs Syndrome Covered
Table Global Restless Legs Syndrome Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Restless Legs Syndrome Market Size Market Share by Type 2014-2025
Figure Pharmacological Therapy Figures
Table Key Players of Pharmacological Therapy
Figure Non-Pharmacological Therapy Figures
Table Key Players of Non-Pharmacological Therapy
Table Global Restless Legs Syndrome Market Size Growth by Application 2014-2025 (Million US$)
Figure < 35 Years Old Case Studies
Figure 35-50 Years Old Case Studies
Figure > 50 Years Old Case Studies
Figure Restless Legs Syndrome Report Years Considered
Table Global Restless Legs Syndrome Market Size 2014-2025 (Million US$)
Figure Global Restless Legs Syndrome Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Restless Legs Syndrome Market Size by Regions 2014-2025 (Million US$)
Table Global Restless Legs Syndrome Market Size by Regions 2014-2019 (Million US$)
Table Global Restless Legs Syndrome Market Share by Regions 2014-2019
Figure Global Restless Legs Syndrome Market Share by Regions 2014-2019
Figure Global Restless Legs Syndrome Market Share by Regions 2019
Table Market Top Trends
Table Global Restless Legs Syndrome Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Restless Legs Syndrome Market Share by Manufacturers (2014-2019)
Figure Global Restless Legs Syndrome Market Share by Manufacturers in 2018
Table Global Restless Legs Syndrome Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Restless Legs Syndrome Product/Solution/Service
Table Date of Enter into Restless Legs Syndrome Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Restless Legs Syndrome Market Size by Type (2014-2019) (Million US$)
Table Global Restless Legs Syndrome Market Size Share by Type (2014-2019)
Figure Global Restless Legs Syndrome Market Size Market Share by Type (2014-2019)
Table Global Restless Legs Syndrome Market Size by Application (2014-2019) (Million US$)
Table Global Restless Legs Syndrome Market Size Share by Application (2014-2019)
Figure Global Restless Legs Syndrome Market Size Market Share by Application (2014-2019)
Figure Global Restless Legs Syndrome Revenue Market Share by Application in 2018
Figure United States Restless Legs Syndrome Market Size 2014-2019 (Million US$)
Table United States Key Players Restless Legs Syndrome Revenue (2018-2019) (Million US$)
Table United States Key Players Restless Legs Syndrome Market Share (2018-2019)
Table United States Restless Legs Syndrome Market Size by Type (2014-2019) (Million US$)
Table United States Restless Legs Syndrome Market Share by Type (2014-2019)
Table United States Restless Legs Syndrome Market Size by Application (2014-2019) (Million US$)
Table United States Restless Legs Syndrome Market Share by Application (2014-2019)
Figure Europe Restless Legs Syndrome Market Size 2014-2019 (Million US$)
Table Europe Key Players Restless Legs Syndrome Revenue (2018-2019) (Million US$)
Table Europe Key Players Restless Legs Syndrome Market Share (2018-2019)
Table Europe Restless Legs Syndrome Market Size by Type (2014-2019) (Million US$)
Table Europe Restless Legs Syndrome Market Share by Type (2014-2019)
Table Europe Restless Legs Syndrome Market Size by Application (2014-2019) (Million US$)
Table Europe Restless Legs Syndrome Market Share by Application (2014-2019)
Figure China Restless Legs Syndrome Market Size 2014-2019 (Million US$)
Table China Key Players Restless Legs Syndrome Revenue (2018-2019) (Million US$)
Table China Key Players Restless Legs Syndrome Market Share (2018-2019)
Table China Restless Legs Syndrome Market Size by Type (2014-20189) (Million US$)
Table China Restless Legs Syndrome Market Share by Type (2014-2019)
Table China Restless Legs Syndrome Market Size by Application (2014-2019) (Million US$)
Table China Restless Legs Syndrome Market Share by Application (2014-2019)
Figure Japan Restless Legs Syndrome Market Size 2014-2019 (Million US$)
Table Japan Key Players Restless Legs Syndrome Revenue (2018-2019) (Million US$)
Table Japan Key Players Restless Legs Syndrome Market Share (2018-2019)
Table Japan Restless Legs Syndrome Market Size by Type (2014-2019) (Million US$)
Table Japan Restless Legs Syndrome Market Share by Type (2014-2019)
Table Japan Restless Legs Syndrome Market Size by Application (2014-2019) (Million US$)
Table Japan Restless Legs Syndrome Market Share by Application (2014-2019)
Figure Southeast Asia Restless Legs Syndrome Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Restless Legs Syndrome Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Restless Legs Syndrome Market Share (2018-2019)
Table Southeast Asia Restless Legs Syndrome Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Restless Legs Syndrome Market Share by Type (2014-2019)
Table Southeast Asia Restless Legs Syndrome Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Restless Legs Syndrome Market Share by Application (2014-2019)
Figure India Restless Legs Syndrome Market Size 2014-2019 (Million US$)
Table India Key Players Restless Legs Syndrome Revenue (2018-2019) (Million US$)
Table India Key Players Restless Legs Syndrome Market Share (2018-2019)
Table India Restless Legs Syndrome Market Size by Type (2014-2019) (Million US$)
Table India Restless Legs Syndrome Market Share by Type (2014-2019)
Table India Restless Legs Syndrome Market Size by Application (2014-2019) (Million US$)
Table India Restless Legs Syndrome Market Share by Application (2014-2019)
Figure Central & South America Restless Legs Syndrome Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Restless Legs Syndrome Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Restless Legs Syndrome Market Share (2018-2019)
Table Central & South America Restless Legs Syndrome Market Size by Type (2014-2019) (Million US$)
Table Central & South America Restless Legs Syndrome Market Share by Type (2014-2019)
Table Central & South America Restless Legs Syndrome Market Size by Application (2014-2019) (Million US$)
Table Central & South America Restless Legs Syndrome Market Share by Application (2014-2019)
Table GlaxoSmithKline plc. Company Details
Table GlaxoSmithKline plc. Revenue in Restless Legs Syndrome Business (2014-2019) (Million US$)
Figure GlaxoSmithKline plc. Revenue Growth Rate in Restless Legs Syndrome Business (2014-2019)
Table GlaxoSmithKline plc. Recent Development
Table Ligand Pharmaceuticals Incorporated Company Details
Table Ligand Pharmaceuticals Incorporated Revenue in Restless Legs Syndrome Business (2014-2019)(Million US$)
Figure Ligand Pharmaceuticals Incorporated Revenue Growth Rate in Restless Legs Syndrome Business (2014-2019)
Table Ligand Pharmaceuticals Incorporated Recent Development
Table axxonis Pharma AG Company Details
Table axxonis Pharma AG Revenue in Restless Legs Syndrome Business (2014-2019)(Million US$)
Figure axxonis Pharma AG Revenue Growth Rate in Restless Legs Syndrome Business (2014-2019)
Table axxonis Pharma AG Recent Development
Table Kyowa Hakko Kirin Company Details
Table Kyowa Hakko Kirin Revenue in Restless Legs Syndrome Business (2014-2019)(Million US$)
Figure Kyowa Hakko Kirin Revenue Growth Rate in Restless Legs Syndrome Business (2014-2019)
Table Kyowa Hakko Kirin Recent Development
Table Jazz Pharmaceuticals Company Details
Table Jazz Pharmaceuticals Revenue in Restless Legs Syndrome Business (2014-2019)(Million US$)
Figure Jazz Pharmaceuticals Revenue Growth Rate in Restless Legs Syndrome Business (2014-2019)
Table Jazz Pharmaceuticals Recent Development
Table Omeros Corporation Company Details
Table Omeros Corporation Revenue in Restless Legs Syndrome Business (2014-2019)(Million US$)
Figure Omeros Corporation Revenue Growth Rate in Restless Legs Syndrome Business (2014-2019)
Table Omeros Corporation Recent Development
Table Manhattan Pharmaceuticals Company Details
Table Manhattan Pharmaceuticals Revenue in Restless Legs Syndrome Business (2014-2019)(Million US$)
Figure Manhattan Pharmaceuticals Revenue Growth Rate in Restless Legs Syndrome Business (2014-2019)
Table Manhattan Pharmaceuticals Recent Development
Table Boehringer Ingelheim GmbH Company Details
Table Boehringer Ingelheim GmbH Revenue in Restless Legs Syndrome Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim GmbH Revenue Growth Rate in Restless Legs Syndrome Business (2014-2019)
Table Boehringer Ingelheim GmbH Recent Development
Table UCB SA Company Details
Table UCB SA Revenue in Restless Legs Syndrome Business (2014-2019)(Million US$)
Figure UCB SA Revenue Growth Rate in Restless Legs Syndrome Business (2014-2019)
Table UCB SA Recent Development
Table Global Restless Legs Syndrome Market Size by Regions (Million US$) 2019-2025
Figure Global Restless Legs Syndrome Market Size Share by Regions (2019-2025)
Figure Global Restless Legs Syndrome Market Size Share by Regions in 2025
Figure United States Restless Legs Syndrome Market Size Forecast (2019-2025)(Million USD)
Figure Europe Restless Legs Syndrome Market Size Forecast (2019-2025)(Million USD)
Figure China Restless Legs Syndrome Market Size Forecast (2019-2025)(Million USD)
Figure Japan Restless Legs Syndrome Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Restless Legs Syndrome Market Size Forecast (2019-2025)(Million USD)
Figure India Restless Legs Syndrome Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Restless Legs Syndrome Market Size Forecast (2019-2025)(Million USD)
Table Global Restless Legs Syndrome Market Size by Product (2019-2025) (Million US$)
Figure Global Restless Legs Syndrome Market Size by Product (2019-2025)
Figure Global Restless Legs Syndrome Market Size by Product in 2025
Table Global Restless Legs Syndrome Market Size by Application (2019-2025) (Million US$)
Figure Global Restless Legs Syndrome Market Size by Application (2019-2025)
Figure Global Restless Legs Syndrome Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の腫瘍随伴症候群の治療市場：市場規模・現状・予測 A paraneoplastic syndrome is a rare group of disorder that is triggered by an abnormal immune system response caused by the neoplasm. This syndrome mostly occurs when cancer-fighting antibodies mistakenly attack normal cells in the nervous system. The prevalence of this disorder can be typically see…- 世界の梨状筋症候群市場：市場規模・現状・予測 Piriformis syndrome is a rare neuromuscular condition that is caused when the piriformis muscle compresses the sciatic nerve. The piriformis muscle is a flat, band-like muscle located in the buttock near the upper region of the hip joint. Piriformis syndrome mostly occurs in adults and can affect in…
- 世界のスタージウェーバー症候群（SWS）治療市場：市場規模・現状・予測 Sturge-Weber syndrome or Sturge-Weber-Krabbe disease, sometimes referred to as encephalotrigeminal angiomatosis, is a rare congenital neurological and skin disorder. It is one of the phakomatoses and is often associated with port-wine stains of the face, glaucoma, seizures, mental retardation, and i…
- 世界のQT延長症候群の治療市場：市場規模・現状・予測 Long QT syndrome is a condition which affects repolarization of the heart after a heartbeat. This results in an increased risk of an irregular heartbeat which can result in palpitations, fainting, drowning, or sudden death. These episodes can be triggered by exercise or stress. Other associated symp…
- 世界の骨髄異形成症候群（MDS）薬市場：市場規模・現状・予測 Myelodysplastic syndrome is caused by mutation of one or more genes that control development of blood cells. It is one of the most common malignant hematological diseases that affects five out of every 100,000 people in U.S. annually. An estimated 60,000 people in U.S. live with MDS, and approximate…